FUNDAMENTALS · Fundamentals · US Healthcare

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Fundamentals 2026 — Revenue Analysis | SniperIQ

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is a US-listed Healthcare company in Medical - Devices with a market capitalization of

.0B, trading at
0.69 on the NASDAQ. This SniperIQ fundamentals page covers Lumexa Imaging Holdings, Inc. Common Stock's valuation, profitability (net margin -5.2%), revenue (
.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap
.0B
Net Margin-5.2%
Revenue (FY25)
.0B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Lumexa Imaging Holdings, Inc. Common Stock's market cap?

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has a market capitalization of approximately

.0B, trading at
0.69 on the NASDAQ. Market cap moves with the live share price.

What is Lumexa Imaging Holdings, Inc. Common Stock's P/E ratio?

Lumexa Imaging Holdings, Inc. Common Stock's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Lumexa Imaging Holdings, Inc. Common Stock?

Lumexa Imaging Holdings, Inc. Common Stock runs a net profit margin of -5.2%, a gross margin of 10.5%, and an operating margin of -0.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Lumexa Imaging Holdings, Inc. Common Stock generate?

Lumexa Imaging Holdings, Inc. Common Stock reported revenue of

.0B for fiscal year 2025, with net income of -$47M and earnings per share (EPS) of -0.66. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Lumexa Imaging Holdings, Inc. Common Stock pay a dividend?

Lumexa Imaging Holdings, Inc. Common Stock does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Lumexa Imaging Holdings, Inc. Common Stock financially healthy?

Lumexa Imaging Holdings, Inc. Common Stock carries a debt-to-equity ratio of 1.61x and a current ratio of 1.40x, with a market beta of 2.41. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Lumexa Imaging Holdings, Inc. Common Stock a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Lumexa Imaging Holdings, Inc. Common Stock (LMRI) the key facts are: market cap

.0B, revenue
.0B, 52-week range 6.45-19.45. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Lumexa Imaging Holdings, Inc. Common Stock's full fundamentals live

Get Lumexa Imaging Holdings, Inc. Common Stock's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Kindstar Globalgene Technology (9960) fundamentals · GoodRx Holdings (GDRX) fundamentals · Dingdang Health Technology Group (9886) fundamentals · PROCEPT BioRobotics (PRCT) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons